2025-04-01 15:59:03
Latest Post
Josts Engineering Company Ltd announces Exclusive Distribution Agreement for 'Zowell' Brand Warehouse Material Handling Equipment in India
Eris Lifesciences designates Gopal Agrawal and Nita Borkar in leadership roles
PennWhite to build a new manufacturing plant in India
Shree Rama Multi-Tech Ltd commences commercial production with new Tubing Machine- JECL Engineering Ltd commences commercial production of Material Handling Equipments
Stock Report
Indrayani Biotech Ltd consolidated Q4FY24 PAT up at Rs. 4.73 crore
Posted On : 2024-05-31 10:32:22( TIMEZONE : IST )
INDRAYANI BIOTECH LTD. has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 45.4135 crores during the period ended March 31, 2024 as compared to Rs. 39.1752 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 4.7329 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 1.0823 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.58 for the period ended March 31, 2024 as compared to Rs. 0.22 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 45.4135 crs | ₹39.1752 crs |  15.92% |
| Net Profit | ₹4.7329 crs | ₹1.0823 crs | 337.30% |
| EPS | ₹0.58 | ₹0.22 | 163.64% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 45.4135 crores during the period ended March 31, 2024 as compared to Rs.51.2975 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.4.7329 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.1.4442 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.58 for the period ended March 31, 2024 as compared to Rs.0.29 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 45.4135 crs | ₹51.2975 crs |  -11.47% |
| Net Profit | ₹4.7329 crs | ₹1.4442 crs | 227.72% |
| EPS | ₹0.58 | ₹0.29 | 100.00% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.167.4406 crores during the Financial Year ended March 31, 2024 as compared to Rs.167.4145 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.10.4225 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.11.9307 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.1.40 for the Financial Year ended March 31, 2024 as compared to Rs.2.05 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹167.4406 crs | ₹167.4145 crs | 0.02% |
| Net Profit | ₹10.4225 crs | ₹11.9307 crs | -12.64% |
| EPS | ₹1.40 | ₹2.05 | -31.71% |
Shares of INDRAYANI BIOTECH LTD. was last trading in BSE at Rs. 47.98 as compared to the previous close of Rs. 48.96. The total number of shares traded during the day was 38566 in over 253 trades.
The stock hit an intraday high of Rs. 49.74 and intraday low of 47.90. The net turnover during the day was Rs. 1872313.00.
